|
Re: Apabetalone Inhibits SARS-CoV-2 Infection at Levels Comparable to Approved Antiviral
|
4
|
Resverlogix Corp.
|
Mar 15, 2021 11:02AM
|
|
Re: Anyone read Chinese?
|
1
|
Resverlogix Corp.
|
Oct 26, 2017 03:01PM
|
|
Re: Anyone else find it odd......
|
4
|
Resverlogix Corp.
|
Aug 19, 2019 04:56PM
|
|
Re: Anyone ......
|
3
|
Resverlogix Corp.
|
Oct 10, 2015 09:40AM
|
|
Re: Anybody ever post this link already?
|
6
|
Resverlogix Corp.
|
Apr 14, 2023 11:00AM
|
|
Re: Another Week
|
4
|
Resverlogix Corp.
|
Oct 21, 2022 07:05PM
|
|
Re: Another RVX-208 Poster at IAS 2015 May 26
|
4
|
Resverlogix Corp.
|
May 19, 2015 02:49PM
|
|
Re: Another Report of Exempt Distribution
|
2
|
Resverlogix Corp.
|
Mar 19, 2023 08:35PM
|
|
Re: Another reason
|
6
|
Resverlogix Corp.
|
Jan 10, 2022 05:19PM
|
|
Re: Another Exempt Distribution -2022-06-02
|
7
|
Resverlogix Corp.
|
Jun 08, 2022 11:33AM
|
|
Re: Another Exempt Distribution -2022-06-02
|
4
|
Resverlogix Corp.
|
Jun 05, 2022 01:12PM
|
|
Re: Another country listed on EU Clinical Trial Register for BETonMACE
|
4
|
Resverlogix Corp.
|
Dec 09, 2015 03:32PM
|
|
Re: Another country listed on EU Clinical Trial Register for BETonMACE
|
2
|
Resverlogix Corp.
|
Dec 10, 2015 08:35AM
|
|
Re: Another country listed on EU Clinical Trial Register for BETonMACE
|
3
|
Resverlogix Corp.
|
Dec 10, 2015 04:48PM
|
|
Re: Another article. Mechanism related.
|
9
|
Resverlogix Corp.
|
Jun 14, 2022 01:23PM
|
|
Re: And we wait.....
|
5
|
Zenith Epigenetics
|
Jan 31, 2018 05:26PM
|
|
Re: And we wait.....
|
3
|
Zenith Epigenetics
|
Jan 26, 2018 12:11PM
|
|
Re: And there's the news, 3 month loan extension....
|
4
|
Resverlogix Corp.
|
May 04, 2019 02:14PM
|
|
Re: Anacetrapib Officially Bites the Dust
|
6
|
Resverlogix Corp.
|
Oct 26, 2017 05:08PM
|
|
Re: Anacetrapib Officially Bites the Dust
|
5
|
Resverlogix Corp.
|
Oct 26, 2017 03:09PM
|
